A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up

A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04208139

Enrollment

Registered

2019-12-23

Start date

2020-03-14

Completion date

2020-10-01

Last updated

2022-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Pulmonary Embolism (Disorder)

Brief summary

IVUS Evaluation of the Bioabsorbable Sentry IVC Filter 3-5 Years Post Deployment Follow up

Detailed description

IVUS Evaluation of the Bioabsorbable Sentry IVC Filter 3-5 Years Post Deployment Follow up

Interventions

DIAGNOSTIC_TESTIVUS

IVUS

Study design

Observational model

OTHER

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years of age * Signed the informed consent document * Participants from the SENTRY clinical trial willing to undergo one time IVUS evaluation ( outpatient )

Exclusion criteria

* Any filter that remained non converted.

Design outcomes

Primary

Measure	Time frame	Description
Patency of the inferior vena cava	3-5 years	—
Cylindrical frame integrity	3-5 years	Cylindrical frame integrity
Impact of the Sentry cylindrical frame on the vessel wall evaluation for endothelialization and neointimal hyperplasia and wall dynamics	3-5 years	Impact of the Sentry cylindrical frame on the vessel wall evaluation for endothelialization and neointimal hyperplasia and wall dynamics
Presence and characterization of adherent thrombus	3-5 years	Presence and characterization of adherent thrombus

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026